financetom
Business
financetom
/
Business
/
BRIEF-BP Could Be Split In Sale - CNBC Citing Sources
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-BP Could Be Split In Sale - CNBC Citing Sources
Jun 25, 2025 9:40 AM

June 25 (Reuters) -

* BP COULD BE SPLIT IN SALE - CNBC CITING SOURCES

Source text:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Serve Robotics Advancing Autonomy Platform With Multiple Revenue Streams, Oppenheimer Says
Serve Robotics Advancing Autonomy Platform With Multiple Revenue Streams, Oppenheimer Says
Mar 26, 2026
11:08 AM EDT, 03/26/2026 (MT Newswires) -- Serve Robotics ( SERV ) has turned several of its core technologies into revenue-generating channels as it advances its autonomy platform, Oppenheimer said in a Thursday note. The company is making demonstrable progress on an autonomy platform that the market may be underappreciating while expanding multiple revenue streams. Serve's data capture and processing...
Tower Semiconductor's New Strategy Indicates Upside From Optics, Wedbush Says
Tower Semiconductor's New Strategy Indicates Upside From Optics, Wedbush Says
Mar 26, 2026
11:07 AM EDT, 03/26/2026 (MT Newswires) -- Tower Semiconductor's ( TSEM ) new plans to expand cleanroom space suggest the company's management has increased confidence that demand will exceed its optics-oriented expansion, Wedbush said in a note Thursday. Tower Semiconductor ( TSEM ) has signed a framework agreement to buy full ownership of Japan-based Tower Partners Semiconductor's 12-inch fab and...
Kodiak Sciences Stock Hits 52-Week High - Here's Why
Kodiak Sciences Stock Hits 52-Week High - Here's Why
Mar 26, 2026
Kodiak Sciences Inc. ( KOD ) shares are up on Thursday following the announcement of positive topline results in the GLOW2 Phase 3 study for Zenkuda (tarcocimab tedromer) in treating diabetic retinopathy. Diabetic retinopathy is an eye complication of diabetes caused by high blood sugar damaging retinal blood vessels, leading to leakage, bleeding, and potential vision loss. The stock’s movement...
Chewy Posts Solid Q4, Indicates AI-Related Efficiency Benefits Ahead
Chewy Posts Solid Q4, Indicates AI-Related Efficiency Benefits Ahead
Mar 26, 2026
Shares of Chewy Inc ( CHWY ) rose in early trading on Thursday after the company reported upbeat fourth-quarter (Q4) results. Here are the key analyst insights: Guggenheim Securities analyst Steven Forbes reiterated a Buy rating and price target of $45. Needham analyst Bernie McTernan reaffirmed a Hold rating on the stock. Check out other analyst stock ratings. Guggenheim Securities:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved